Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2009
05/14/2009WO2009060229A1 Sulfatase enzymes
05/14/2009WO2009060225A2 Rodenticide
05/14/2009WO2009060184A1 Mycobacterium antigens
05/14/2009WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
05/14/2009WO2009060124A2 Use of oligonucleotides with modified bases in hybridization of nucleic acids
05/14/2009WO2009060122A2 Use of oligonucleotides with modified bases as antiviral agents
05/14/2009WO2009060040A1 Yield enhancement in plants by modulation of a seuss-like co-regulator
05/14/2009WO2009059805A1 Catenate for immunostimulation
05/14/2009WO2009059804A2 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells
05/14/2009WO2009059554A1 Single nucleotide polymorphism in human toll-like receptor 7 gene and its use
05/14/2009WO2009059485A1 An epsp synthase with high glyphosate resistance and its encoded sequence
05/14/2009WO2009059422A1 Rotavirus vaccine
05/14/2009WO2009059417A1 Association of single nucleotide polymorphisms in the cbfa2t1 and decr1 genes with performance and carcass merit of beef cattle
05/14/2009WO2009059414A1 Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer
05/14/2009WO2009042971A3 Synthetic 5'utrs, expression vectors, and methods for increasing transgene expression
05/14/2009WO2009042910A9 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis
05/14/2009WO2009042734A3 Radiation-resistant mutants of a halophilic archaeon and uses thereof
05/14/2009WO2009042162A3 Compositions and methods for inhibiting interleukin pathways
05/14/2009WO2009039300A3 Compositions comprising hif-1 alpha sirna and methods of use thereof
05/14/2009WO2009039199A3 Compositions comprising stat5 sirna and methods of use thereof
05/14/2009WO2009039189A3 Compositions comprising stat3 sirna and methods of use thereof
05/14/2009WO2009037402A3 Hpiv-2 variants and medical applications thereof
05/14/2009WO2009036997A4 Truncated secretory aspartyl proteinase 2
05/14/2009WO2009035554A3 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
05/14/2009WO2009032930A3 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
05/14/2009WO2009029293A3 Nucleic acid compounds for inhibiting myc gene expression and uses thereof
05/14/2009WO2009027830A3 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
05/14/2009WO2009021295A3 Inhibition of alpha synuclein toxicity
05/14/2009WO2008157559A3 Generation of plants with altered oil, protein or fiber content
05/14/2009WO2008154251A3 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
05/14/2009WO2008153733A3 Vectors and methods for genetic immunization
05/14/2009WO2008140615A3 Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
05/14/2009WO2008127352A3 Knockout mice for pr01105, pro1279 or pro1783 coding genes
05/14/2009WO2008115844A3 Stable, functional chimeric cytochrome p450 holoenzymes
05/14/2009WO2008100292A3 Modified vaccinia virus strains for use in diagnostic and therapeutic methods
05/14/2009WO2008097461A3 Hepcidin and hepcidin antibodies
05/14/2009WO2008091627A3 Methods and organisms for growth-coupled production of 3-hydroxypropionic acid
05/14/2009WO2008037458A8 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
05/14/2009WO2008035216A3 Generation of heavy-chain only antibodies in transgenic animals
05/14/2009WO2007056043A3 Use of potassium channels for identifying compounds that have an insecticidal effect
05/14/2009WO2007038056A3 Protease-resistant forms of vegf-d, method of making and method of use
05/14/2009WO2007021756A3 Methods for characterizing biological molecule modulators
05/14/2009WO2006060630A3 Apparatuses and methods for determining protease activity
05/14/2009WO2006017621A3 IRAK1c SPLICE VARIANT AND ITS USE
05/14/2009WO2005115469A3 Estrogen modulation of ifn-gamma-mediated conditions and diseases
05/14/2009WO2005113823A3 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
05/14/2009WO2005113809A3 Novel fibroblast growth factor and nucleic acids encoding same
05/14/2009WO2005105142A3 Recombinant reverse transcriptases
05/14/2009WO2005079363A3 Aptamer therapeutics useful in the treatment of complement-related disorders
05/14/2009WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's)
05/14/2009US20090126049 Seed composition and method for reducing and preventing the release of genetically manipulated pollen
05/14/2009US20090126047 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time
05/14/2009US20090126046 Plants having improved growth characteristics and method for making the same
05/14/2009US20090126044 Synthetic genes encoding cry1ac
05/14/2009US20090126043 Generation of plants with improved pathogen resistance and drought tolerance
05/14/2009US20090126042 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
05/14/2009US20090126041 Regeneration
05/14/2009US20090126040 Plant Vernalization Independence (VIP) Genes, Proteins, and Methods Of Use
05/14/2009US20090126038 Rna constructs
05/14/2009US20090126035 Rice Hybrid XL729
05/14/2009US20090126034 Environmentally Stable Sensors and Methods of Using the Same
05/14/2009US20090126033 Method of selective breeding based on ob genotype
05/14/2009US20090126032 Method to produce cloned embryos and adults from cultured cells
05/14/2009US20090124795 Mitochondrial Dosimeter
05/14/2009US20090124793 Corticotropin releasing factor 2 receptor agonists
05/14/2009US20090124777 Compositions for Delivering Nucleic Acids to Cells
05/14/2009US20090124592 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
05/14/2009US20090124567 Influenza Therapeutic
05/14/2009US20090124549 administering to a patient infected with mycobacterium tuberculosis, a therapeutically effective amount of an isolated polypeptide ( a polypeptide covalently linked to a carrier); protective immune response
05/14/2009US20090124545 Novel nucleic acid encoding a novel protein of candida albicans and uses thereof
05/14/2009US20090124544 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
05/14/2009US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases
05/14/2009US20090124516 System for Providing Control Reactions for Real Time RT-PCR
05/14/2009US20090124515 Methods and compositions for preparation of selectively protected carbohydrates
05/14/2009US20090124014 Method for homologous recombination in fungal cells
05/14/2009US20090124012 Toxin/antitoxin systems and methods for regulating cellular growth, metabolic engineering and production of recombinant proteins
05/14/2009US20090124009 Antisense modulation of ptp1b expression
05/14/2009US20090124004 Insect desiccation resistance genes and uses thereof
05/14/2009US20090124003 Modulators of odorant receptors
05/14/2009US20090124002 Alpha-1d calcium channel expressed in atrium
05/14/2009US20090124000 Recombinant Vectors
05/14/2009US20090123999 Nucleotide sequences invovled in plant disease resistance
05/14/2009US20090123998 Signature encoding sequence for genetic preservation
05/14/2009US20090123991 Retrons for gene targeting
05/14/2009US20090123984 Transformed plants accumulating terpenes
05/14/2009US20090123980 Process for producing l-arginine, l-ornithine or l-citrulline
05/14/2009US20090123977 System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts
05/14/2009US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
05/14/2009US20090123973 Methods of Making Modular Fusion Protein Expression Products
05/14/2009US20090123972 Staphylococcal nuclease fusion proteins for the production of recombinant peptides
05/14/2009US20090123971 Compositions of aminoacyl-tRNA synthetase and uses thereof
05/14/2009US20090123970 Glycosylated mammalian ngal and use thereof
05/14/2009US20090123969 Novel fluorescent protein and gene encoding the same
05/14/2009US20090123967 Modified spider silk proteins
05/14/2009US20090123966 Hybrid portable origin of replication plasmids
05/14/2009US20090123964 Novel Gene GMS 08
05/14/2009US20090123954 Multicolor bioluminescent visualization probe set, or single-molecule-format multicolor bioluminescent visualization probe
05/14/2009US20090123945 Cholinergic/serotoninergic receptor and uses thereof
05/14/2009US20090123944 Bioassays
05/14/2009US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist